Insider Trading - Edgewise Therapeutics Inc. (EWTX)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Edgewise Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-03-30
Purchase
2021-03-30
3:42 pm
Edgewise Therapeutics Inc. EWTX Flynn James E
Deerfield Mgmt IV L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Private Design Fund IV L.P.
10% Owner
625,000 $16 $10,000,000 3,933,137
(Indirect)
View
2021-03-30
Purchase
2021-03-31
4:36 pm
Edgewise Therapeutics Inc. EWTX Novo Holdings A/S
10% Owner
625,000 $16 $10,000,000 5,587,207
(Direct)
View
2021-03-30
Purchase
2021-03-31
7:10 pm
Edgewise Therapeutics Inc. EWTX ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
OrbiMed Genesis GP LLC
Director
10% Owner
359,375 $16 $5,750,000 13,359,456
(Indirect)
View
2021-03-30
Purchase
2021-03-31
7:11 pm
Edgewise Therapeutics Inc. EWTX Thompson Peter A.
Director
10% Owner
359,375 $16 $5,750,000 13,359,456
(Indirect)
View
2021-03-30
Purchase
2021-03-31
7:12 pm
Edgewise Therapeutics Inc. EWTX ROOT JONATHAN D
Director
15,625 $16 $250,000 3,489,168
(Indirect
Direct)
View
2021-09-23
Sale
2021-09-27
7:32 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
58,546 $18.3 $1,071,422 205,554
(Direct)
View
2021-09-28
Sale
2021-09-30
7:16 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
26,454 $17.1 $452,483 179,100
(Direct)
View
2021-10-01
Sale
2021-10-05
6:33 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
5,778 $18.24 $105,409 173,322
(Direct)
View
2021-10-06
Sale
2021-10-08
6:00 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
21,028 $18.39 $386,743 152,294
(Direct)
View
2021-10-11
Sale
2021-10-13
6:51 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
1,270 $18.02 $22,885 151,024
(Direct)
View
2021-10-14
Sale
2021-10-18
7:48 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
7,182 $18.17 $130,483 143,842
(Direct)
View
2021-11-01
Sale
2021-11-03
7:00 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
44,172 $17.88 $789,909 99,670
(Direct)
View
2021-11-04
Sale
2021-11-08
7:11 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
29,451 $19.82 $583,823 70,219
(Direct)
View
2021-11-09
Sale
2021-11-12
5:24 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
69,740 $19.91 $1,388,788 479
(Direct)
View
2021-11-15
Sale
2021-11-17
6:05 pm
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
479 $19.11 $9,155 0
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-03-30
Conversion
2021-03-30
3:42 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX Flynn James E
Deerfield Mgmt IV L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Private Design Fund IV L.P.
10% Owner
3,308,137 $0 3,933,137
(Indirect)
View
2021-03-30
Conversion
2021-03-30
5:12 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
681,812 $0 681,812
(Direct)
View
2021-03-30
Conversion
2021-03-31
4:36 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX Novo Holdings A/S
10% Owner
9,924,414 $0 5,587,207
(Direct)
View
2021-03-30
Conversion
2021-03-31
7:10 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
OrbiMed Genesis GP LLC
Director
10% Owner
25,732,796 $0 13,359,456
(Indirect)
View
2021-03-30
Conversion
2021-03-31
7:11 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX Thompson Peter A.
Director
10% Owner
25,732,796 $0 13,359,456
(Indirect)
View
2021-03-30
Conversion
2021-03-31
7:12 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX ROOT JONATHAN D
Director
6,947,086 $0 3,489,168
(Indirect)
View
2021-04-30
Option Award
2021-05-04
4:34 pm
N/A
2031-04-30
Edgewise Therapeutics Inc. EWTX Donovan Joanne M.
CMO
160,000 $0 160,000
(Direct)
View
2021-08-17
Option Award
2021-08-19
5:09 pm
N/A
2031-08-17
Edgewise Therapeutics Inc. EWTX KOCH KEVIN
CEO
400,000 $0 400,000
(Direct)
View
2021-08-17
Option Award
2021-08-19
5:09 pm
N/A
2031-08-17
Edgewise Therapeutics Inc. EWTX Carruthers R Michael
CFO
120,000 $0 120,000
(Direct)
View
2021-08-17
Option Award
2021-08-19
5:09 pm
N/A
2031-08-17
Edgewise Therapeutics Inc. EWTX Derakhshan Behrad
Chief Business Officer
140,000 $0 140,000
(Direct)
View
2021-08-17
Option Award
2021-08-19
5:09 pm
N/A
2031-08-17
Edgewise Therapeutics Inc. EWTX Donovan Joanne M.
CMO
160,000 $0 160,000
(Direct)
View
2021-08-17
Option Award
2021-08-19
5:09 pm
N/A
2031-08-17
Edgewise Therapeutics Inc. EWTX MOORE JOHN R
General Counsel
120,000 $0 120,000
(Direct)
View
2021-08-17
Option Award
2021-08-19
5:10 pm
N/A
2031-08-17
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
120,000 $0 120,000
(Direct)
View
2021-11-30
Exercise
2021-12-01
6:20 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
147,585 $0.18 302,937
(Direct)
View
2021-11-30
Exercise
2021-12-01
6:20 pm
N/A
2027-08-08
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
172,585 $0 302,937
(Direct)
View
2021-11-30
Exercise
2021-12-01
6:20 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX Russell Alan J
Chief Scientific Officer
25,000 $0.45 302,937
(Direct)
View